Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry
Authors:
- 27 June 2014
- journal article
- review article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 23 (8) , 779-786
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Final results from 18 years of the International Lamotrigine Pregnancy RegistryNeurology, 2011
- The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003–2009Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancyNeurology, 2008
- ErrataBirth Defects Research Part A: Clinical and Molecular Teratology, 2008
- Management of Epilepsy during PregnancyDrugs, 2007
- EURAP: An International Registry of Antiepileptic Drugs and PregnancyEpilepsia, 2004
- North American Antiepileptic Drug Pregnancy RegistryEpilepsia, 2004
- The Teratogenicity of Anticonvulsant DrugsNew England Journal of Medicine, 2001
- Valproate and spina bifida.BMJ, 1989
- Malformations Due to Presumed Spontaneous Mutations in Newborn InfantsNew England Journal of Medicine, 1989